Main > NEUROLOGY. > Multiple Sclerosis > Treatment > Estriol > Co.: USA. A. (Phase II/III/Patent)
Co.: USA. A. (Phase II/III/Patent)'s subsections
Company
Oral Estriol
Patent>Assignee, Claims, No., Etc.
Patent>USA Expiration: 04.24.22
Relapsing-Remitting MS
TradeMark
Web-Site
Web-Site (PR>2010. 02.22.2010)
Co.: USA. A. (Phase II/III/Patent)'s products
This section has no products